We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Owen Mumford

Owen Mumford Ltd. is an industry leader in the medical device market with a diverse product range including advanced ... read more Featured Products: More products

Download Mobile App





Owen Mumford Presents Cutting-Edge Capillary Blood Sampling Devices for POC Testing

By LabMedica International staff writers
Posted on 15 Nov 2022

Owen Mumford (Oxford, UK) is once again exhibiting at this year’s MEDICA in Düsseldorf, Germany where it is presenting tomorrow’s medical device technology today. More...

Attracting several thousand exhibitors from more than 50 countries, MEDICA is the world’s largest event for the medical sector, where each year, leading individuals from the fields of business, research, and politics converge alongside tens of thousands of decision-makers.

At MEDICA 2022, Owen Mumford is showcasing its pioneering products from three different ranges: safety pen needles, venous blood collection set and capillary blood sampling devices. The company’s portfolio of safety pen needles for insulin injections includes the Unifine SafeControl device which is designed to protect healthcare professionals, balancing both safety and control during the injection process. Compatible with all major brands of injection pens, it is available in a variety of sizes and features a manual push tab for easy, one-handed activation of the safety mechanism. It has both a visual and audible confirmation that the safety mechanism has been activated, making it a dual safety pen needle.

Among Owen Mumford’s featured products at MEDICA is its Unistik Touch safety lancet featuring ground-breaking comfort zone technology which helps to minimize the pain of capillary blood sampling. Unistik Touch safety lancet is designed to make capillary sampling as simple and seamless as possible. With one-touch activation, users can simply press the device against the sample site, allowing it to activate automatically under pressure. Once activated, the needle retracts into the body of the device, minimizing the risk of re-use, cross-infection and injury. At MEDICA 2022, Owen Mumford is also showcasing its recently launched venous blood collection portfolio consisting of new devices such as, the Unistik ShieldLock and Unistik VacuFlip. This range provides safety, comfort and quality for healthcare professionals when performing venous blood collection procedures.

Related Links:
Owen Mumford 


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Chagas Disease Test
LIAISON Chagas
New
C-Reactive Protein Assay
OneStep C-Reactive Protein (CRP) RapiCard InstaTest
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.